Harel Insurance Investments & Financial Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $150K | Buy |
3,518
+1,086
| +45% | +$59K | ﹤0.01% | 362 |
|
|
2026
Q1 | $153K | Sell |
2,432
-2,404
| -50% | -$192K | ﹤0.01% | 327 |
|
|
2025
Q4 | $461K | Sell |
4,836
-3,070
| -39% | -$301K | ﹤0.01% | 218 |
|
|
2025
Q3 | $771K | Buy |
7,906
+3,562
| +82% | +$369K | 0.01% | 207 |
|
|
2025
Q2 | $467K | Sell |
4,344
-9
| -0.2% | -$911 | 0.01% | 229 |
|
|
2025
Q1 | $439K | Buy |
+4,353
| New | +$438K | 0.01% | 214 |
|
|
2024
Q4 | – | Sell |
-867
| Closed | -$73K | – | 474 |
|
|
2024
Q3 | $73K | Sell |
867
-2,033
| -70% | -$160K | ﹤0.01% | 308 |
|
|
2024
Q2 | $223K | Sell |
2,900
-300
| -9% | -$22K | ﹤0.01% | 251 |
|
|
2024
Q1 | $219K | Sell |
3,200
-470
| -13% | -$30.2K | ﹤0.01% | 243 |
|
|
2023
Q4 | $207K | Sell |
3,670
-931
| -20% | -$49.7K | ﹤0.01% | 286 |
|
|
2023
Q3 | $246K | Buy |
4,601
+629
| +16% | +$33K | ﹤0.01% | 274 |
|
|
2023
Q2 | $212K | Sell |
3,972
-4,400
| -53% | -$230K | 0.01% | 307 |
|
|
2023
Q1 | $415K | Sell |
8,372
-1,000
| -11% | -$47.1K | 0.01% | 252 |
|
|
2022
Q4 | $433K | Buy |
9,372
+2,580
| +38% | +$112K | 0.01% | 218 |
|
|
2022
Q3 | $267K | Sell |
6,792
-999
| -13% | -$40.1K | 0.01% | 272 |
|
|
2022
Q2 | $290K | Buy |
+7,791
| New | +$317K | 0.01% | 301 |
|
|
2021
Q3 | – | Sell |
-3,149
| Closed | -$439K | – | 690 |
|
|
2021
Q2 | $439K | Sell |
3,149
-1,608
| -34% | -$67.7K | 0.01% | 490 |
|
|
2021
Q1 | $614K | Buy |
4,757
+502
| +12% | +$19K | 0.01% | 474 |
|
|
2020
Q4 | $492K | Sell |
4,255
-2,183
| -34% | -$78.7K | 0.01% | 367 |
|
|
2020
Q3 | $246K | Buy |
6,438
+4,994
| +346% | +$192K | 0.01% | 281 |
|
|
2020
Q2 | $51K | Buy |
1,444
+1,304
| +931% | +$47K | ﹤0.01% | 400 |
|
|
2020
Q1 | $5K | Sell |
140
-2,914
| -95% | -$114K | ﹤0.01% | 407 |
|
|
2019
Q4 | $138K | Sell |
3,054
-9,947
| -77% | -$416K | 0.01% | 241 |
|
|
2019
Q3 | $529K | Buy |
13,001
+11,001
| +550% | +$466K | 0.03% | 105 |
|
|
2019
Q2 | $86K | Hold |
2,000
| – | – | ﹤0.01% | 262 |
|
|
2019
Q1 | $77K | Hold |
2,000
| – | – | ﹤0.01% | 231 |
|
|
2018
Q4 | $71K | Hold |
2,000
| – | – | ﹤0.01% | 266 |
|
|
2018
Q3 | $77K | Hold |
2,000
| – | – | ﹤0.01% | 298 |
|
|
2018
Q2 | $65K | Hold |
2,000
| – | – | ﹤0.01% | 284 |
|
|
2018
Q1 | $55K | Hold |
2,000
| – | – | ﹤0.01% | 300 |
|
|
2017
Q4 | $50K | Sell |
2,000
-9,620
| -83% | -$265K | ﹤0.01% | 324 |
|
|
2017
Q3 | $339K | Hold |
11,620
| – | – | 0.03% | 130 |
|
|
2017
Q2 | $322K | Sell |
11,620
-4,013
| -26% | -$107K | 0.03% | 138 |
|
|
2017
Q1 | $385K | Buy |
+15,633
| New | +$380K | 0.03% | 108 |
|
|
2016
Q3 | – | Sell |
-1,800
| Closed | -$42K | – | 495 |
|
|
2016
Q2 | $42K | Buy |
+1,800
| New | +$38.9K | 0.01% | 366 |
|
Other funds holding BSX
Harel Insurance Investments & Financial Services's BSX Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services increased its Boston Scientific (BSX) stake by 45% in Q2 2026, buying an estimated $59K and bringing the position to 3,518 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #362.
Harel Insurance Investments & Financial Services first reported a position in BSX in Q2 2016 and has held it in 35 quarters since. The position peaked at $771K in Q3 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Harel Insurance Investments & Financial Services held 3,518 shares of Boston Scientific worth $150K as of Q2 2026.
- Harel Insurance Investments & Financial Services bought 1,086 Boston Scientific shares in Q2 2026, an estimated $59K.
- Boston Scientific made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #362 holding.
- Harel Insurance Investments & Financial Services first reported a position in Boston Scientific in Q2 2016 and has held it in 35 quarters since.
- Harel Insurance Investments & Financial Services's Boston Scientific position peaked at $771K in Q3 2025.
- 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.